Effects of hydrogen-rich water on abnormalities in a SHR.Cg-Lepr cp /NDmcr rat - A metabolic syndrome rat model

Medical Gas Research

Volumn 1, Issue 1, 2011, Pages

  Hashimoto, Michio ^a   Katakura, Masanori ^a   Nabika, Toru ^a   Tanabe, Yoko ^a   Hossain, Shahdat ^a,b   Tsuchikura, Satoru ^c   Shido, Osamu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b JAHANGIRNAGAR UNIVERSITY   (Bangladesh)

^c Disease Model Cooperative Research Association   (Japan)

Author keywords

hydrogen rich water; metabolic syndrome model rats; oxidative stress; renal glomerulosclerosis

Indexed keywords

ALBUMIN; ANTIOXIDANT; CREATININE; HYDROGEN RICH WATER; NITROGEN; SCAVENGER; UNCLASSIFIED DRUG; UREA; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; CREATININE URINE LEVEL; DRUG EFFICACY; FLUID INTAKE; GLOMERULOSCLEROSIS; MALE; METABOLIC SYNDROME X; MICTURITION; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL;

EID: 84863681930     PISSN: None     EISSN: 20459912     Source Type: Journal    
DOI: 10.1186/2045-9912-1-26     Document Type: Article

References (17)

1. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S, Nat Med 2007 13 688 694 10.1038/nm1577 17486089 (Pubitemid 46889750)
2. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Dzau VJ, Hypertension 2001 37 1047 1052 11304501 (Pubitemid 32304002)
3. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Taniyama Y, Griendling KK, Hypertension 2003 42 1075 1081 10.1161/01.HYP.0000100443.09293.4F 14581295 (Pubitemid 37549058)
4. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai H, Seino Y, Yamada Y, Diabetes 1999 48 927 932 10.2337/diabetes.48.4.927 10102716 (Pubitemid 29153099)
5. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. Kurella M, Lo JC, Chertow GM, J Am Soc Nephrol 2005 16 2134 2140 10.1681/ASN.2005010106 15901764 (Pubitemid 41716445)
6. Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome-an open label pilot study. Nakao A, Toyoda Y, Sharma P, Evans M, Guthrie N, J Clin Biochem Nutr 2010 46 140 149 10.3164/jcbn.09-100 20216947
7. Effect of dietary sucrose on the SHR/N-corpulent rat: a new model for insulin-independent diabetes. Michaelis OEt, Ellwood KC, Judge JM, Schoene NW, Hansen CT, Am J Clin Nutr 1984 39 612 618 6369957 (Pubitemid 14135375)
8. In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy. Nangaku M, Izuhara Y, Usuda N, Inagi R, Shibata T, Sugiyama S, Kurokawa K, van Ypersele de Strihou C, Miyata T, Nephrol Dial Transplant 2005 20 2661 2669 10.1093/ndt/gfi096 16188903 (Pubitemid 41672264)
9. Elevated plasma levels of bilirubin in patients with neurotrauma reflect its pathophysiological role in free radical scavenging. Dohi K, Satoh K, Ohtaki H, Shioda S, Miyake Y, Shindo M, Aruga T, In Vivo 2005 19 855 860 16097438 (Pubitemid 41065144)
10. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Uehara Y, Hirawa N, Kawabata Y, Suzuki T, Ohshima N, Oka K, Ikeda T, Goto A, Toyo-oka T, Kizuki K, Hypertension 1994 24 770 778 7995636
11. Oral hydrogen water prevents chronic allograft nephropathy in rats. Cardinal JS, Zhan J, Wang Y, Sugimoto R, Tsung A, McCurry KR, Billiar TR, Nakao A, Kidney Int 2010 77 101 109 10.1038/ki.2009.421 19907413
12. Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S, Cancer Chemother Pharmacol 2009 64 753 761 10.1007/s00280-008-0924-2 19148645
13. Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. Izuhara Y, Nangaku M, Inagi R, Tominaga N, Aizawa T, Kurokawa K, van Ypersele de Strihou C, Miyata T, J Am Soc Nephrol 2005 16 3631 3641 10.1681/ASN.2005050522 16236804 (Pubitemid 46211284)
14. Microalbuminuria as a predictor of clinical diabetic nephropathy. Mogensen CE, Kidney Int 1987 31 673 689 10.1038/ki.1987.50 3550239 (Pubitemid 17012586)
15. Thiazolidinediones provide better renoprotection than insulin in an obese, hypertensive type II diabetic rat model. Ohtomo S, Izuhara Y, Takizawa S, Yamada N, Kakuta T, van Ypersele de Strihou C, Miyata T, Kidney Int 2007 72 1512 1519 10.1038/sj.ki.5002570 17898696 (Pubitemid 350197953)
16. Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Cai J, Kang Z, Liu WW, Luo X, Qiang S, Zhang JH, Ohta S, Sun X, Xu W, Tao H, Li R, Neurosci Lett 2008 441 167 172 10.1016/j.neulet.2008.05.077 18603371
17. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, Kitawaki J, Imai S, Nakano K, Ohta M, Adachi T, Obayashi H, Yoshikawa T, Nutr Res 2008 28 137 143 10.1016/j.nutres.2008.01.008 19083400 (Pubitemid 351452069)